CTKB - Cytek Biosciences, Inc.
3.86
0.090 2.332%
Share volume: 612,649
Last Updated: 04-28-2025
Measuring And Control Equipment/Lab Analytical Instruments:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$3.77
0.09
0.02%
Fundamental analysis
21%
Profitability
0%
Dept financing
6%
Liquidity
75%
Performance
33%
Performance
5 Days
1.05%
1 Month
-3.74%
3 Months
-32.16%
6 Months
-19.75%
1 Year
-35.99%
2 Year
-67.15%
Key data
Stock price
$3.86
DAY RANGE
$3.76 - $3.87
52 WEEK RANGE
$3.27 - $7.63
52 WEEK CHANGE
-$35.77
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
Company detail
CEO: Wen B. Jiang
Region: US
Website: cytekbio.com
Employees: 500
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Region: US
Website: cytekbio.com
Employees: 500
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Cytek Biosciences, Inc. provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also provides reagents and kits, including cFluor reagents.
Recent news
